Skip to main content

Biotechnology Startups

Updated October 2026

Companies in the biotechnology sector developing innovative solutions and technologies.

Explore 5,823 recently funded biotechnology companies with verified founder contact information and fundraising data.

Total Companies
5,823
Total Funding
$367.0M
Avg Funding
$14.7M
Global Reach
11
countries

Top Cities for Biotechnology

Brisbane
Berlin
New Suffolk
Warsaw
San Francisco
Ann Arbor

Recently Funded Companies

Export
Brisbane, United States

āshibio is a privately held biotechnology business exploring innovative therapies to treat bone and connective tissue ailments.

$40.0M raised
Jun 2024

Founder Contacts

41,000+ verified contacts

Berlin, Germany

Cambrium is engineering biology to create high-performance proteins.

Jun 2024

Founder Contacts

41,000+ verified contacts

New Suffolk, United States

ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways.

$1.0M raised
Jun 2024

Founder Contacts

41,000+ verified contacts

Warsaw, Poland

Quantum was created to develop solutions that address specific difficulties in cardiac surgery, cardiology, and respiratory medicine.

$10.1M raised
Jun 2024

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Delve Bio is a biotechnology company that provides molecular insights for the precision care of patients.

$35.0M raised
Jun 2023

Founder Contacts

41,000+ verified contacts

Ann Arbor, United States

Newhaptics is a microfluidic technology company that specializes in full-page digital braille and tactile graphics displays.

Jun 2023

Founder Contacts

41,000+ verified contacts

Limerick, Ireland

Hooke Bio is a biotechnology company providing engineering solutions for the analysis of 3D microtissues for preclinical drug development

$2.7M raised
Jun 2023

Founder Contacts

41,000+ verified contacts

Frederick, United States

Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.

$24.0M raised
Jun 2023

Founder Contacts

41,000+ verified contacts

San Diego, United States

Replicate Bioscience develops self-replicating RNA therapeutics and vaccines delivering immunity at lower doses across multiple diseases.

$3.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Houdini Bio develops computational synthetic biology tools to redesign DNA constructs for improved genetic medicines.

$1.9M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Paris, France

Oria Bioscience is a pure biotechnology company that produces intact organelles for therapeutic opportunities.

$3.1M raised
Jun 2025

Founder Contacts

41,000+ verified contacts

Zürich, Switzerland

Myriad Optics is a new bacterial contamination detection solutions for the food industry.

$184K raised
Jun 2025

Founder Contacts

41,000+ verified contacts

Hørsholm, Denmark

AdaptVac is a joint-venture between ExpreS2ion Biotech and University of Copenhagen spin-out NextGen Vaccines.

$12.4M raised
Jun 2025

Founder Contacts

41,000+ verified contacts

Helsinki, Finland

Nanoform is a pioneering company driven by a passion for innovation and a commitment to solving our partners’ problems.

$5.8M raised
Jun 2025

Founder Contacts

41,000+ verified contacts

Paris, France

Anoat Therapeutics develops an innovative, disease-modifying approach in Cystic Fibrosis.

$2.2M raised
Jun 2023

Founder Contacts

41,000+ verified contacts

Istanbul, Turkey

Bloocell is a biotechnology firm that researches artificial tissues as well as develops equipment for the medical sector.

$900K raised
Jun 2023

Founder Contacts

41,000+ verified contacts

Alameda, United States

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

$25.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Alameda, United States

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

$25.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Alameda, United States

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

$25.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Chester, United Kingdom

Memento Medicines is a biotech developing bispecific antibody therapies for eye diseases.

$93.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Skokie, United States

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

$50.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Wilmington, United States

iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.

Jun 2026

Founder Contacts

41,000+ verified contacts

Toronto, Canada

Psyence develops natural psilocybin products for the treatment of psychological trauma and mental health disorders

$438K raised
Jun 2025

Founder Contacts

41,000+ verified contacts

Vancouver, Canada

Cynaptec is a biopharmaceutical company focused on creating novel treatments for neurological and psychiatric conditions.

$6.0M raised
Jun 2025

Founder Contacts

41,000+ verified contacts

Toronto, Canada

Microbiome-Derived Biotherapeutics

$256K raised
Jun 2025

Founder Contacts

41,000+ verified contacts

Showing 1476 to 1500 of 5,823 companies

About the Biotechnology Startup Ecosystem

The biotechnology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biotechnology

Biotechnology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biotechnology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biotechnology Funding Breakdown

Here is how funding is distributed among the 5,823 biotechnology companies tracked in the VCBacked database.

Average Funding
$14.7M
Total Funding Tracked
$367.0M
Countries Represented
11

Distribution by Funding Stage

Other25 companies

Top Cities for Biotechnology

1.Alameda
3 companies$75.0M
2.Paris
2 companies$5.3M
3.Toronto
2 companies$694K
4.Brisbane
1 companies$40.0M
5.Berlin
1 companiesUndisclosed

Related Industries

Companies in the biotechnology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biotechnology Startups?

Perfect for: B2B sales teams targeting biotechnology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked